Aurobindo Pharma Limited (NSE:AUROPHARMA)

India · Delayed Price · Currency is INR

1,247.30

+15.40 (1.25%)

Mar 9, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Products	317.24B	290.02B	248.55B	234.55B	247.75B
Pharmaceutical Products Growth	9.39%	16.68%	5.97%	-5.32%	7.26%
Total	317.24B	290.02B	248.55B	234.55B	247.75B
Total Growth	9.39%	16.68%	5.97%	-5.32%	7.26%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	36.01B	34.02B	27.48B	26.70B	20.14B
India Growth	5.86%	23.79%	2.93%	32.58%	-10.16%
USA	144.78B	139.80B	112.42B	105.21B	121.17B
USA Growth	3.56%	24.36%	6.86%	-13.18%	3.76%
Europe	92.36B	75.63B	72.43B	78.81B	81.22B
Europe Growth	22.12%	4.42%	-8.10%	-2.97%	11.62%
Rest of the World	44.08B	40.56B	36.22B	23.83B	25.21B
Rest of the World Growth	8.67%	11.98%	51.97%	-5.46%	32.55%
Total	317.24B	290.02B	248.55B	234.56B	247.75B
Total Growth	9.39%	16.68%	5.97%	-5.32%	7.26%

Source: S&P Global Market Intelligence.